Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
about
Development of neuropeptide drugs that cross the blood-brain barrier.Neuroprotection in experimental stroke with targeted neurotrophins.Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.Vector-mediated drug delivery to the brain.Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.Agile delivery of protein therapeutics to CNSA novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.Transferrin-antibody fusion proteins are effective in brain targetingGlycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.Blood-brain barrier transport of therapeutics via receptor-mediationProdrug approaches for CNS deliveryStreptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptorShuttle-mediated drug delivery to the brain.Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex.Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro.Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro.Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders.Targeting of drugs to cell surface receptors.Inhibition of monocyte adhesion to brain-derived endothelial cells by dual functional RNA chimeras.A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review.Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.Production and characterization of fusion proteins containing transferrin and nerve growth factor.Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers.Isolation and culture of bovine endothelial cells of endoneurial origin.
P2860
Q33569277-64A3087D-E210-4811-AFFB-28490C58B7D0Q33569623-7C852B04-6599-48D4-9098-EBAF540AA204Q33625084-97699080-B85E-4945-B3F2-C8690C4A9B3AQ33956192-521A1495-7933-4C99-BB67-F767BE218B0BQ33996836-0BA0E9EC-4A14-4AF1-970A-C041937E8804Q34079647-765BBD59-DCF0-44FD-981D-0CEC7D220959Q34130082-7504AB79-BFF4-4579-B49D-C5753C2EC40DQ34239620-14DD76A9-2BE4-4206-B8B2-27306FD321A0Q34506062-47531D73-7B18-4ABA-9BF8-E3D8C7547F9AQ35616945-BD184FC4-6D0C-4E35-A499-470D98F10BF8Q36874295-8178D1AB-F7AA-4D3A-843F-E9AC1E9917DBQ37150860-DD2CE4F7-CCCF-47F5-A712-A3823C0CC399Q37184666-09D9F515-221C-4CD2-A9C1-77B55673EED9Q37372948-BA340370-A9A4-461F-8C7B-DB33E3B8904EQ37896550-D3B83EA5-C19F-475D-A556-9B9CA29C374DQ38774154-65FCDA7F-888D-4B0D-920B-874FD0F73F7AQ38946806-E8AA42BE-3556-4710-BE4C-0C7DBD30F8B8Q39177694-CE343095-AC01-4DFA-B0FB-5E36F9B74E90Q39738982-3FA81B1C-8489-4E33-A08F-73148172F0EAQ41506607-4C6AF64F-42EF-4D1B-9FCF-57C9DB6EA2E7Q42015646-22D4EF13-1C92-4F4B-9DBB-B435B04FD5BBQ42458889-7091DDFE-F5D3-4198-AFFA-5D356A930438Q47606935-B5E40E2C-06B4-43B1-BA1D-CB0211A819E5Q48377810-9504BB40-9E24-45DF-888B-C3D56DEF5BB2Q48455901-68500AAA-8CEC-4684-9125-BF2BE6111F94Q48615485-3D332994-B58C-4C2E-B480-E50E431D3DE7
P2860
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@ast
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@en
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@nl
type
label
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@ast
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@en
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@nl
prefLabel
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@ast
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@en
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
@nl
P2093
P2860
P356
P1476
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery
@en
P2093
E M Landaw
T Yoshikawa
P2860
P304
P356
10.1073/PNAS.90.7.2618
P407
P577
1993-04-01T00:00:00Z